Aralez signs LOI to divest Canadian spec pharma operations to Nuvo; later signs definitive agreement
- Large Molecule
- Medical Devices
- Specialty Pharmaceuticals
- Payment Includes Cash
- Full Acquisition
- Intra-Biotech Deal
- Includes Contract
- Acquisition of Private Biotech
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.